Financials in USD. Standardized financial statements.
A compact view of how ViaDerma, Inc. turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $600,498 | $540,648 | $514,007 | $11,468 | $10,395 | $45,973 | $44,691 | $251,981 | $191,777 | $19.01M |
| Revenue Growth? | +11.1% | +5.2% | +4382.1% | +10.3% | -77.4% | +2.9% | -82.3% | +31.4% | -99.0% | 0.0% |
| Cost of Revenue? | $196 | $197 | $2,672 | $637 | $537 | $21,476 | $8,026 | $11,701 | $10,950 | $13.35M |
| Gross Profit? | $600,302 | $540,451 | $511,335 | $10,831 | $9,858 | $24,497 | $36,665 | $240,280 | $180,827 | $5.66M |
| Gross Margin? | +100.0% | +100.0% | +99.5% | +94.4% | +94.8% | +53.3% | +82.0% | +95.4% | +94.3% | +29.8% |
| Operating Expenses? | $415,029 | $295,259 | $183,215 | $81,501 | $347,619 | $734,963 | $630,064 | $112,832 | $87,080 | $1.62M |
| Operating Income? | $185,270 | $245,190 | $328,120 | -$70,670 | -$337,760 | -$710,470 | -$593,400 | $127,450 | $93,750 | $4.04M |
| EBITDA? | $80,709 | $689,836 | -$882,911 | -$282,604 | -$338,075 | -$1.36M | -$1.13M | $128,964 | $147,361 | $6.86M |
| Income Before Tax | $4,097 | $590,674 | -$994,178 | -$431,673 | -$599,270 | -$3.00M | -$1.52M | -$121,806 | $27,121 | $3.55M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | -$2 | -$4 | -$4 | -$4 | $874,341 |
| Net Income? | $4,097 | $590,674 | -$994,178 | -$431,673 | -$599,270 | -$3.00M | -$1.52M | -$121,806 | $27,121 | $2.67M |
| EPS? | $0.00 | $0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $0.00 | $19.50 |
| Diluted EPS? | $0.00 | $0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $0.00 | $19.50 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality